Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysisNikolaj Frost, Jens Kollmeier, Martin Witzenrath et al.|Lung Cancer|2023Cited by 18